Sg Americas Securities, LLC Vanda Pharmaceuticals Inc. Transaction History

Sg Americas Securities, LLC

$27.6 Billion
Q3 2024

A detailed history of Sg Americas Securities, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 20,402 shares of VNDA stock, worth $95,481. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,402

Previous 10,822 88.52%

Holding current value

$95,481

Previous $61,000 57.38%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 03, 2024	BUY	$4.61 - $6.34 $44,163 - $60,737	9,580 Added 88.52%	20,402 $96,000
Q2 2024 Jul 12, 2024	BUY	$3.91 - $6.5 $42,314 - $70,343	10,822 New	10,822 $61,000
Q4 2023 Jan 12, 2024	BUY	$3.38 - $4.58 $8,409 - $11,395	2,488 Added 12.59%	22,248 $94,000
Q3 2023 Oct 13, 2023	BUY	$4.28 - $6.57 $84,572 - $129,823	19,760 New	19,760 $85,000
Q1 2023 Apr 28, 2023	SELL	$6.18 - $7.99 $548,450 - $709,080	-88,746 Reduced 72.08%	34,379 $233,000
Q4 2022 Feb 02, 2023	BUY	$6.87 - $10.96 $672,147 - $1.07 Million	97,838 Added 386.91%	123,125 $910,000
Q3 2022 Oct 31, 2022	BUY	$9.44 - $11.76 $143,563 - $178,846	15,208 Added 150.89%	25,287 $250,000
Q2 2022 Jul 29, 2022	SELL	$9.31 - $11.84 $883,193 - $1.12 Million	-94,865 Reduced 90.4%	10,079 $110,000
Q1 2022 Apr 29, 2022	BUY	$10.84 - $16.55 $118,361 - $180,709	10,919 Added 11.61%	104,944 $1.19 Million
Q4 2021 Feb 07, 2022	BUY	$15.69 - $21.14 $356,241 - $479,983	22,705 Added 31.84%	94,025 $1.48 Million
Q3 2021 Nov 01, 2021	BUY	$15.35 - $21.27 $1.09 Million - $1.52 Million	71,320 New	71,320 $1.22 Million
Q2 2021 Aug 12, 2021	SELL	$15.71 - $21.51 $335,691 - $459,625	-21,368 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$13.42 - $20.28 $151,122 - $228,373	11,261 Added 111.42%	21,368 $321,000
Q4 2020 Feb 04, 2021	SELL	$9.77 - $13.81 $2.87 Million - $4.06 Million	-293,757 Reduced 96.67%	10,107 $133,000
Q3 2020 Nov 09, 2020	BUY	$9.32 - $12.02 $2.66 Million - $3.43 Million	285,711 Added 1573.91%	303,864 $2.94 Million
Q2 2020 Jul 20, 2020	BUY	$9.66 - $12.02 $63,582 - $79,115	6,582 Added 56.88%	18,153 $208,000
Q1 2020 Apr 30, 2020	BUY	$7.5 - $16.8 $86,782 - $194,392	11,571 New	11,571 $120,000
Q3 2019 Nov 04, 2019	SELL	$12.27 - $15.79 $145,387 - $187,095	-11,849 Closed	0 $0
Q2 2019 Jul 29, 2019	SELL	$13.37 - $18.85 $184,813 - $260,563	-13,823 Reduced 53.84%	11,849 $167,000
Q1 2019 Apr 29, 2019	BUY	$17.59 - $31.05 $272,645 - $481,275	15,500 Added 152.38%	25,672 $472,000
Q4 2018 Feb 01, 2019	BUY	$18.97 - $31.47 $192,962 - $320,112	10,172 New	10,172 $266,000
Q3 2018 Nov 06, 2018	SELL	$18.25 - $23.0 $131,162 - $165,301	-7,187 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$13.95 - $19.15 $3,222 - $4,423	231 Added 3.32%	7,187 $137,000
Q1 2018 May 03, 2018	BUY	$14.05 - $20.2 $97,731 - $140,511	6,956 New	6,956 $117,000
Q4 2017 Jan 24, 2018	SELL	$12.85 - $18.1 $113,439 - $159,786	-8,828 Closed	0 $0
Q3 2017 Nov 07, 2017	BUY	$15.4 - $18.85 $135,951 - $166,407	8,828	8,828 $158,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.2M

Call Options Held

165K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $265M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.

Account

Sg Americas Securities, LLC Vanda Pharmaceuticals Inc. Transaction History